StemCells Inc. (STEM) Secures $30 Million Financing Commitment From Lincoln Park Capital
6/4/2013 9:52:48 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEWARK, Calif., June 4, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research and drug discovery, has entered into an agreement with Lincoln Park Capital Fund, LLC ("Lincoln Park"), an institutional investor based in Chicago, Illinois, under which the Company has the right to sell up to $30.0 million of common stock to Lincoln Park. Proceeds from any sales of stock will be used for general corporate purposes.
Help employers find you! Check out all the jobs and post your resume.